Paper Details

  1. Home
  2. Paper Details

Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.

Author: ChaisewikulR, HuttonJ L, MarsonA G, PriviteraM D

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review examines the effectiveness of levetiracetam, a new antiepileptic drug, as an additional treatment for patients with epilepsy who experience seizures despite taking other medications (drug-resistant partial epilepsy). This type of epilepsy affects up to 30% of patients. The review summarizes current research on levetiracetam's potential to improve outcomes in these patients.
Paper Details　
Original Abstract of the Article :
The majority of patients with epilepsy have a good prognosis and their seizures are well controlled by a single antiepileptic drug. However, up to 30% develop refractory seizures, particularly those with partial seizures. In this review, we summarise the current evidence regarding a new antiepilepti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD001901

データ提供：米国国立医学図書館（NLM）

Levetiracetam: A Potential Solution for Drug-Resistant Epilepsy

Epilepsy, a neurological disorder characterized by seizures, can be challenging to manage, especially in cases of drug resistance. This study reviews the current evidence regarding levetiracetam, a new antiepileptic drug, as an add-on treatment for drug-resistant localization-related (partial) epilepsy. The review synthesizes research findings, providing an overview of the potential benefits and considerations for using levetiracetam in this specific patient population.

Levetiracetam: A Promising Add-on Treatment for Drug-Resistant Epilepsy

The review highlights the potential of levetiracetam as a valuable add-on treatment option for individuals with drug-resistant localization-related epilepsy. Its efficacy in controlling seizures, coupled with its manageable side effect profile, suggests its potential to improve patient outcomes.

Navigating Drug-Resistant Epilepsy: Exploring New Treatment Options

This review underscores the importance of exploring new treatment options for individuals with drug-resistant epilepsy. Levetiracetam represents a potential solution to improve seizure control and enhance quality of life for those struggling with this challenging condition.

Dr. Camel's Conclusion

The desert of drug-resistant epilepsy can be a desolate place for patients seeking relief. This review suggests that levetiracetam might offer a ray of hope, providing a potential pathway toward improved seizure control and a more manageable journey for those with this challenging condition.

Date :
  1. Date Completed 2001-12-07
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

11279737

DOI: Digital Object Identifier

10.1002/14651858.CD001901

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.